Estee Lauder ( EL ) and other club stocks with meaningful exposure to the Chinese economy jumped Friday on news that BioNTech’s ( BNTX ) Covid vaccine will soon be available to foreign residents living in China. We are cautiously optimistic about vaccine development, raising hopes that Beijing will soften its restrictive pandemic policies after … Read more
Pfizer is set to report earnings on Tuesday, a week and a half after an executive told investors the company was considering a list price for its Covid-19 vaccine of between $110 and $130 per adult dose, higher than analysts had expected. The surprise has prompted analysts to rethink their estimates for next year’s Covid-19 … Read more
Pfizer Inc. gave some details about its plans to sell the Covid-19 vaccine it developed with BioNTech SE on the commercial market in the United States, saying it expects to price the shot at $110 to $130 per dose for adults. The drugmaker is still negotiating with health insurers but expects the discussions to lead … Read more
Jakub Porzycki | NurPhoto | Getty Images Pfizer and its German partner BioNTech on Thursday said its new omicron boosters significantly increased protective antibodies against the dominant omicron BA.5 subvariant in adults in the first direct human data released to the public on the new shots. The study looked at blood samples taken from 40 … Read more
The redesigned Covid-19 booster from Pfizer Inc. and BioNTech SE generated a strong immune response against the Omicron substrains BA.4 and BA.5, the companies said. The data, which the companies reported in a press release Thursday, provides the first window into how the new images rolling out across the U.S. are faring. An early look … Read more
AstraZeneca PLC produced one of the world’s most widely used Covid-19 vaccines. As demand for the shot ebbs, the company is focusing on tackling breast cancer and another respiratory virus. Now the company is scaling back production of its vaccine while lining up sequels to some blockbusters that have helped drive the company’s growth in … Read more
Biopharma companies are having more clinical success treating Alzheimer’s disease and obesity and are taking new approaches in oncology, creating more mega-blockbuster drugs, according to Bank of America. Analyst Geoff Meacham has identified 20 drugs that have the potential to generate $10 billion or more in annual sales by 2030 within the universe of companies … Read more
A healthcare worker administers a dose of the Pfizer-BioNTech Covid-19 vaccine at a vaccination clinic at the Peabody Institute Library in Peabody, Massachusetts, U.S., Wednesday, Jan. 26, 2022. Vanessa Leroy | Bloomberg | Getty Images Covid-19 vaccination is associated with a small increase in the length of a woman’s menstrual cycle, delaying the onset of … Read more
Pfizer Inc. and BioNTech SE asked US health authorities to clear the use of its updated Covid-19 booster in children aged 5 to 11 years. The companies made the request Monday as reformulated shots for people 12 and older roll out across the country. Health officials are urging people to get shots to increase protection … Read more
General Mills Inc. GIS -1.99% Companies that sell and make what we eat are fighting for consumer loyalty as inflation sends prices higher. Sales rose for Cheerios maker General Mills as more people want to save money by eating at home, while profits fell by about 16% at the dining chain Darden Restaurants Inc. The … Read more